Industry Insights
Get to know us
After months of meticulous preparation and construction, the Phase II Factory Expansion Project of Kconti Med Technology (Suzhou) Co., Ltd. has been successfully completed and officially put into operation. As a crucial milestone in the company's development journey, this expansion not only demonstrates our firm commitment to deepening our presence in the medical nitinol alloy sector, but also embodies our long-term promise to customers and the market, injecting strong impetus into the high-quality development of the enterprise.
The new Phase II factory is located at No. 1888 Jujin Road, Zhangpu Town, Kunshan City, Suzhou. Leveraging Kunshan's high-quality industrial ecosystem as the top county among China's Top 100 Counties (with an annual regional GDP exceeding 50 billion yuan and a total industrial output value of designated-sized enterprises reaching 1.0811 trillion yuan), it enjoys complete industrial chain supporting facilities and a highly efficient business environment. With an additional investment of 20 million yuan and a newly added factory area of 6,500 square meters, the core upgrade highlights are as follows:
Substantial Increase in Production Capacity: Multiple modern production lines and high-end equipment have been introduced. After commissioning, the monthly production capacity of small-specification products can reach 3,000 meters, and that of large-specification products has been increased to 3,000 meters simultaneously, which can fully meet the growing order demands of global customers.
Enhanced R&D Capabilities: An independent R&D production line has been added, focusing on the innovation of medical nitinol alloy materials and process optimization, further strengthening the core technological barriers.
Upgraded Service Experience: A professional visitor passage has been built as supporting facilities, which can meet multiple needs such as customer inspections, partner exchanges and system audits, comprehensively displaying the production process and technological strength.
At present, the visitor passage of the Phase II factory has been officially opened. We sincerely invite customers, partners and friends from all walks of life to visit and guide us, to discuss cooperation and seek common development!
About Kconti Med
Founded in 2022, Kconti Med Technology (Suzhou) Co., Ltd. is a high-tech enterprise without capital intervention, focusing on the R&D and manufacturing of medical nitinol alloys. The company's founder has 10 years of experience in the operation and management of production-oriented enterprises. Relying on the core advantages of "advanced foreign craftsmanship + high-quality domestic equipment platform", after two years of preliminary technological R&D, the company has built a complete product system.
We specialize in providing medical nitinol tubes, nitinol wires and nitinol material CDMO services. Committed to becoming a world-renowned innovative supplier of medical nitinol materials with high-quality and customized material solutions, we strive to empower the development of global medical and health undertakings.
After months of meticulous preparation and construction, the Phase II Factory Expansion Project of Kconti Med Technology (Suzhou) Co., Ltd. has been successfully completed and officially put into operation. As a crucial milestone in the company's development journey, this expansion not only demonstrates our firm commitment to deepening our presence in the medical nitinol alloy sector, but also embodies our long-term promise to customers and the market, injecting strong impetus into the high-quality development of the enterprise.
The new Phase II factory is located at No. 1888 Jujin Road, Zhangpu Town, Kunshan City, Suzhou. Leveraging Kunshan's high-quality industrial ecosystem as the top county among China's Top 100 Counties (with an annual regional GDP exceeding 50 billion yuan and a total industrial output value of designated-sized enterprises reaching 1.0811 trillion yuan), it enjoys complete industrial chain supporting facilities and a highly efficient business environment. With an additional investment of 20 million yuan and a newly added factory area of 6,500 square meters, the core upgrade highlights are as follows:
Substantial Increase in Production Capacity: Multiple modern production lines and high-end equipment have been introduced. After commissioning, the monthly production capacity of small-specification products can reach 3,000 meters, and that of large-specification products has been increased to 3,000 meters simultaneously, which can fully meet the growing order demands of global customers.
Enhanced R&D Capabilities: An independent R&D production line has been added, focusing on the innovation of medical nitinol alloy materials and process optimization, further strengthening the core technological barriers.
Upgraded Service Experience: A professional visitor passage has been built as supporting facilities, which can meet multiple needs such as customer inspections, partner exchanges and system audits, comprehensively displaying the production process and technological strength.
At present, the visitor passage of the Phase II factory has been officially opened. We sincerely invite customers, partners and friends from all walks of life to visit and guide us, to discuss cooperation and seek common development!
About Kconti Med
Founded in 2022, Kconti Med Technology (Suzhou) Co., Ltd. is a high-tech enterprise without capital intervention, focusing on the R&D and manufacturing of medical nitinol alloys. The company's founder has 10 years of experience in the operation and management of production-oriented enterprises. Relying on the core advantages of "advanced foreign craftsmanship + high-quality domestic equipment platform", after two years of preliminary technological R&D, the company has built a complete product system.
We specialize in providing medical nitinol tubes, nitinol wires and nitinol material CDMO services. Committed to becoming a world-renowned innovative supplier of medical nitinol materials with high-quality and customized material solutions, we strive to empower the development of global medical and health undertakings.